Abiomed Inc (NASDAQ:ABMD)

320.78
Delayed Data
As of 4:00pm ET
 +8.22 / +2.63%
Today’s Change
186.72
Today|||52-Week Range
459.75
+71.16%
Year-to-Date
Sands Capital Management Buys Sarepta Therapeutics Inc, Edwards Lifesciences Corp, Ab...
Nov 14 / GuruFocus News - Paid Partner Content
ABIOMED (ABMD) Shares March Higher, Can It Continue?
Nov 09 / Zacks.com - Paid Partner Content
Here's Why You Should Buy Integer Holdings (ITGR) Stock Now
Nov 14 / Zacks.com - Paid Partner Content
Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know
Nov 06 / Zacks.com - Paid Partner Content
Company News For Nov 13, 2018
Nov 13 / Zacks.com - Paid Partner Content
Abiomed (ABMD) Q2 Earnings Beat, Impella Maintains Momentum
Nov 02 / Zacks.com - Paid Partner Content
Has ABIOMED (ABMD) Outpaced Other Medical Stocks This Year?
Nov 13 / Zacks.com - Paid Partner Content
Stock Market News For Nov 2, 2018
Nov 02 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close312.56
Today’s open310.58
Day’s range301.12 - 324.27
Volume931,334
Average volume (3 months)682,688
Market cap$14.1B
Data as of 4:00pm ET, 11/15/2018

Growth & Valuation

Earnings growth (last year)+109.92%
Earnings growth (this year)+94.33%
Earnings growth (next 5 years)+49.00%
Revenue growth (last year)+33.34%
P/E ratio77.7
Price/Sales22.47
Price/Book20.12

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-3.08-2.22%
TFXTeleflex Inc+4.74+1.85%
WSTWest Pharmaceutical ...+2.14+2.01%
ZBHZimmer Biomet Holdin...+2.28+2.03%
Data as of 4:02pm ET, 11/15/2018

Financials

Next reporting dateJanuary 31, 2019
EPS forecast (this quarter)$0.94
Annual revenue (last year)$593.7M
Annual profit (last year)$112.2M
Net profit margin18.89%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts